Cargando…
Tamoxifen: an FDA approved drug with neuroprotective effects for spinal cord injury recovery
Spinal cord injury (SCI) is a condition without a cure, affecting sensory and/or motor functions. The physical trauma to the spinal cord initiates a cascade of molecular and cellular events that generates a non-permissive environment for cell survival and axonal regeneration. Among these complex set...
Autores principales: | Colón, Jennifer M., Miranda, Jorge D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020807/ https://www.ncbi.nlm.nih.gov/pubmed/27651756 http://dx.doi.org/10.4103/1673-5374.189164 |
Ejemplares similares
-
Tamoxifen and Src kinase inhibitors as neuroprotective/neuroregenerative drugs after spinal cord injury
por: Salgado, Iris K., et al.
Publicado: (2015) -
An insider's perspective on FDA approval of aducanumab
por: Wang, Yaning
Publicado: (2023) -
Does being female provide a neuroprotective advantage following spinal cord injury?
por: Datto, Jeffrey P., et al.
Publicado: (2015) -
Structural and functional reorganization of propriospinal connections promotes functional recovery after spinal cord injury
por: Filli, Linard, et al.
Publicado: (2015) -
Non-invasive brain stimulation to promote motor and functional recovery following spinal cord injury
por: Gunduz, Aysegul, et al.
Publicado: (2017)